Publications for James Q. Del Rosso jqdelrosso@yahoo.com
Del Rosso, J. Q., & Kircik, L. H. (2013). The sequence of inflammation, relevant biomarkers, and the pathogenesis of acne vulgaris: What does recent research show and what does it mean to the clinician? [Supplemental material]. Journal of Drugs in Dermatology, 12(8), s109-s115. This material can be found here.
Del Rosso, J. Q., & Tanghetti, E. (2013). A status report on topical tazarotene in the management of acne vulgaris [Supplemental material]. Journal of Drugs in Dermatology, 12(3), s53-s58. This material can be found here.
Del Rosso, J. Q., Harper, J., Pillai, R., & Moore, R. (2013). Tretinoin photostability: Comparison of micronized tretinoin gel 0.05% and tretinoin gel 0.025% following exposure to fluorescent and solar light. Journal of Clinical and Aesthetic Dermatology, 6(2), 25-28. PMCID: PMC3579485
Del Rosso, J. Q., Reece, B., Smith, K., & Miller, T. (2013). Efinaconazole 10% solution: A new topical treatment for onychomycosis. Journal of Clinical and Aesthetic Dermatology, 6(3), 20–24. PMCID: PMC3613269
Del Rosso, J. Q., Thiboutot, D., Gallo, R., Webster, G., Tanghetti, E., Eichenfield, L., . . . Zaenglein, A. (2013). Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 1: A status report on the disease state, general measures, and adjunctive skin care. Cutis, 92(5), 234-240.
Del Rosso, J. Q., Thiboutot, D., Gallo, R., Webster, G., Tanghetti, E., Eichenfield, L., . . . Zaenglein, A. (2013). Consensus recommendations from the American Acne and Rosacea Society on the management of rosacea, part 2: A status report on topical agents. Cutis, 92(6), 277-284. This material can be found here.
Eichenfield, L. F., Krakowski, A. C., Piggott, C., Del Rosso, J. Q., Baldwin, H., Friedlander, S. F., . . . Thiboutot, D. M. (2013). Evidence-based recommendations for the diagnosis and treatment of pediatric acne [Supplemental material]. Pediatrics, 131(3), S163-S186. doi:10.1542/peds.2013-0490B
Kim, G. K., & Del Rosso, J. Q. (2013). Topical pimecrolimus 1% cream in the treatment of seborrheic dermatitis. Journal of Clinical and Aesthetic Dermatology, 6(2), 29–35. PMCID: PMC3579486
Kircik, L., Lebwohl, M. G., Del Rosso, J. Q., Bagel, J., Gold, L. S., & Weiss, J. S. (2013). Clinical study results of desoximetasone spray, 0.25% in moderate to severe plaque psoriasis. Journal of Drugs in Dermatology, 12(12), 1404-1410.
Levin, J., Friedlander, S. F., & Del Rosso, J. Q. (2013). Atopic dermatitis and the stratum corneum - Part 1: The role of filaggrin in the stratum corneum barrier and atopic skin. Journal of Clinical and Aesthetic Dermatology, 6(10), 16-22. PMCID: PMC3805301
Levin, J., Friedlander, S. F., & Del Rosso, J. Q. (2013). Atopic dermatitis and the stratum corneum part 2: Other structural and functional characteristics of the stratum corneum barrier in atopic skin. Journal of Clinical and Aesthetic Dermatology, 6(11), 49-54. PMCID: PMC3848653
Levin, J., Friedlander, S. F., & Del Rosso, J. Q. (2013). Atopic dermatitis and the stratum corneum - Part 3: The immune system in atopic dermatitis. Journal of Clinical and Aesthetic Dermatology, 6(12), 37-44. PMCID: PMC3997207
Thiboutot, D., & Del Rosso, J. Q. (2013). Acne vulgaris and the epidermal barrier: Is acne vulgaris associated with inherent epidermal abnormalities that cause impairment of barrier functions? Do any topical acne therapies alter the structural and/or functional integrity of the epidermal barrier? Journal of Clinical and Aesthetic Dermatology, 6(2), 18-24. PMCID: PMC3579484
Winkelmann, R. R, Kim, G. K., & Del Rosso, J. Q. (2013). Treatment of cutaneous lupus erythematosus: Review and assessment of treatment benefits based on Oxford Centre for Evidence-based Medicine criteria. Journal of Clinical and Aesthetic Dermatology, 6(1), 27-38. PMCID: PMC3543290
Zaenglein, A. L. , Shamban, A., Webster, G., Del Rosso, J. Q., Dover, J. S., Swinyer, L., . . . Thiboutot, D. (2013). A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris. Journal of Drugs in Dermatology, 12(6), 619-625. This material can be found here.